Aprea Therapeutics Inc — Cash Flow (NASDAQ:APRE) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 41.8 M-37.69 M-25.01 M-12.18 M-13.56 M -13.44 M Cash from investing activities 25.71 K-124.04 K-123.79 K-93.09 K-15.48 K — Cash from financing activities 150.95 K1.75 M682.97 K5.14 M14.82 M 933.07 K Free cash flow 41.78 M-37.69 M-25.01 M-12.27 M-13.57 M -13.44 M

新闻

Aprea Therapeutics Advanced Cancer Trial Shows Promising Results, Stock Soars - Aprea Therapeutics (NASDAQ:APRE)

Aprea公司子宫内膜癌试验中报告第二例部分缓解

Aprea reports second partial response in endometrial cancer trial

Aprea Therapeutics任命Eugene Kennedy为首席医疗顾问

Aprea Therapeutics appoints Eugene Kennedy as chief medical advisor

Aprea Therapeutics (APRE)首席执行官购买价值$25,000股票

Aprea Therapeutics (APRE) CEO buys $25,000 in shares

Aprea Therapeutics股价在早期癌症药物数据公布后下跌

Aprea Therapeutics stock falls after early-stage cancer drug data

Aprea Therapeutics通过私募融资筹集560万美元

Aprea在1期癌症药物试验中报告首例部分缓解

Aprea Therapeutics raises $5.6 million in private placement